Home/Filings/4/0001415889-25-002938
4//SEC Filing

Loerop James 4

Accession 0001415889-25-002938

CIK 0001557746other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:15 PM ET

Size

21.6 KB

Accession

0001415889-25-002938

Insider Transaction Report

Form 4
Period: 2025-02-01
Loerop James
Chief Business Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-0111,25011,250 total
    Common Stock (11,250 underlying)
  • Exercise/Conversion

    Resticted Stock Units

    2025-02-017,50015,000 total
    Common Stock (7,500 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-0114,75044,250 total
    Common Stock (14,750 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2025-02-03+292,300292,300 total
    Exercise: $2.40Exp: 2035-02-02Common Stock (292,300 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-01+11,25096,503 total
  • Tax Payment

    Common Stock

    2025-02-01$2.48/sh15,447$38,309103,306 total
  • Exercise/Conversion

    Common Stock

    2025-02-01+7,500104,003 total
  • Exercise/Conversion

    Common Stock

    2025-02-01+14,750118,753 total
  • Award

    Restricted Stock Units

    2025-02-03+83,50083,500 total
    Common Stock (83,500 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
  • [F3]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2022, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
  • [F4]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
  • [F5]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
  • [F6]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
  • [F7]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Issuer

Aclaris Therapeutics, Inc.

CIK 0001557746

Entity typeother

Related Parties

1
  • filerCIK 0001781549

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:15 PM ET
Size
21.6 KB